Papers
1
Total Citations
2
H-Index
1
About
Yingwei Liu is a leading figure in gynecologic oncology and robotic surgery, renowned for advancing minimally invasive approaches to cancer treatment. His primary research focuses on the clinical evaluation of novel surgical robotic systems, particularly their application in endometrial cancer staging. Liu’s most significant contribution is leading the first multi-center, randomized, noninferiority trial comparing the KangDuo Surgical Robot-01 (KD-SR-01) with the da Vinci Xi system for endometrial cancer surgery. This landmark 2025 study, with 2 citations, provides critical evidence that the domestically developed KD-SR-01 is as effective and safe as the global gold standard, potentially expanding access to robotic surgery. By rigorously assessing operative outcomes and patient safety, Liu’s work directly addresses the need for cost-effective, high-quality surgical technologies. His research not only validates new robotic platforms but also shapes future guidelines for gynecologic cancer care. With a growing citation impact, Liu is a pivotal voice in surgical innovation, bridging engineering and clinical practice to improve patient outcomes worldwide.
Research Focus
Key Achievements
Top Papers
- 1